What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Freeze Cells for Cryopreservation: A Step-by-Step Guide

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Cryopreservation

Cryopreservation is the process of preserving living cells, tissues, or other biological materials by cooling them to ultra-low temperatures, typically below −130°C, at which point all metabolic and biochemical activity ceases. At these temperatures, the kinetic energy of molecules is insufficient to drive enzymatic reactions, and cellular processes such as ATP production, protein synthesis, and membrane transport effectively halt. The goal is not merely to cool cells, but to preserve them in a state from which they can be revived with high viability and retained function.

In cell culture, cryopreservation serves a critical banking function. It allows you to maintain a stable inventory of cells at an early passage number, protecting against genetic drift, contamination, senescence, and phenotypic changes that accumulate with prolonged culture. For example, a laboratory working with a primary cell line such as human umbilical vein endothelial cells (HUVECs) will freeze cells at passage two or three so that all subsequent experiments use cells of similar passage and behavior. Similarly, hybridoma cell lines producing monoclonal antibodies are frozen as master and working banks to ensure a continuous, reproducible supply. The practical importance of cryopreservation extends to clinical applications, where it is used to store stem cells for transplantation, and to the biotechnology industry, where it underpins the maintenance of production cell lines.

The fundamental principle is straightforward: lower the temperature to stop biological time, then restore normal conditions to resume it. The challenge lies in the journey. Cooling cells from 37°C to −196°C (the temperature of liquid nitrogen) exposes them to a series of physical stresses that, if unmanaged, are lethal. Understanding these stresses and the methods to mitigate them is the core of successful cryopreservation.

Why Cryopreserve Cells?

There are several compelling reasons to freeze cells. First, cryopreservation prevents phenotypic drift. Continuous culture selects for cells that grow fastest, which are not necessarily representative of the original population. Freezing early-passage cells creates a reference stock. Second, it saves time and resources. Rather than maintaining dozens of cell lines indefinitely, you can freeze them and thaw only what you need. Third, it provides a safeguard against catastrophic loss. An incubator failure, contamination event, or mycoplasma infection can destroy an entire culture; a frozen bank allows recovery. Fourth, cryopreservation is essential for shipping cells between laboratories, as frozen cells in dry ice or liquid nitrogen transport reliably. Finally, for regulated work such as the production of therapeutic cells, a well-documented cryopreservation protocol is a regulatory requirement.

Historical Context

The foundations of cryopreservation were laid in the mid-20th century. In 1949, Christopher Polge and colleagues at the National Institute for Medical Research in London discovered that glycerol protected fowl spermatozoa from freezing damage. This was a breakthrough because it demonstrated that a chemical additive could prevent the lethal effects of ice formation. In 1959, James Lovelock introduced dimethyl sulfoxide (DMSO) as a cryoprotectant, showing that it protected red blood cells during freezing. Lovelock also proposed the "osmotic stress" hypothesis, which remains central to our understanding of freezing injury. The development of controlled-rate freezers in the 1960s and 1970s allowed precise regulation of cooling rates, and the routine use of liquid nitrogen storage followed. Today, cryopreservation is a standard technique in virtually every cell biology laboratory, yet the underlying principles remain those identified by these early pioneers.

Principles of Cell Freezing

To freeze cells successfully, you must understand what kills them. The primary lethal events during freezing are ice crystal formation, osmotic stress, and the toxic effects of concentrated solutes. These are not independent; they interact in ways that depend on the cooling rate.

Ice Crystal Damage

When water freezes, it forms ice crystals. Inside a cell, ice crystal formation is almost always lethal. Ice crystals can puncture the plasma membrane, disrupt intracellular organelles, and damage the cytoskeleton. The key insight is that ice forms in the extracellular solution first, not inside the cell, because the extracellular fluid has a lower solute concentration and a higher freezing point than the cytoplasm. As the external medium freezes, pure water is sequestered into ice, leaving the remaining extracellular fluid increasingly concentrated with salts and other solutes.

The danger of intracellular ice formation depends on the cooling rate. If cells are cooled slowly, water has time to leave the cell by osmosis as the external osmolality rises. The cell dehydrates and shrinks, and the cytoplasm becomes concentrated enough that it does not freeze internally. If cells are cooled too rapidly, water cannot leave fast enough, and the cytoplasm supercools—remaining liquid below its freezing point—until it eventually freezes internally, forming damaging ice crystals. Conversely, if cells are cooled too slowly, they are exposed to high solute concentrations for extended periods, which is also damaging. There is therefore an optimal cooling rate for each cell type, typically between 0.5°C and 10°C per minute for mammalian cells.

Osmotic Effects

Osmotic stress is a direct consequence of extracellular ice formation. As water is removed from the extracellular solution to form ice, the osmolality of the remaining liquid rises dramatically. For example, at −10°C, the osmolality of a physiological salt solution is approximately 5.5 osmol/kg, roughly ten times the normal value of 0.3 osmol/kg. At −20°C, it exceeds 10 osmol/kg.

The cell responds by losing water to equilibrate with the hypertonic external environment. This water loss causes the cell to shrink. If the shrinkage is too severe or too prolonged, the cell can suffer from "solution effects" injury—damage caused by the high concentration of intracellular solutes, which can denature proteins, destabilize membranes, and cause pH changes. Additionally, the cell membrane, which is a lipid bilayer, undergoes a phase transition during cooling. At temperatures below approximately 10°C, membrane lipids transition from a fluid liquid-crystalline state to a gel phase. This transition alters membrane permeability and can make the cell more susceptible to damage during the subsequent thawing process.

The interplay between cooling rate and osmotic effects is captured by the "two-factor hypothesis" of freezing injury, proposed by Peter Mazur in the 1960s. At slow cooling rates, solution effects dominate; at fast cooling rates, intracellular ice formation dominates. The optimal cooling rate is the one that minimizes both insults.

Role of Cryoprotectants

Cryoprotectants are compounds that reduce freezing injury. They fall into two broad classes: penetrating and non-penetrating. Penetrating cryoprotectants, such as DMSO and glycerol, are small molecules that cross the plasma membrane and accumulate inside the cell. They work by colligative effects—they increase the total solute concentration inside the cell, reducing the amount of water that must leave the cell during freezing and reducing the extent of cell shrinkage. They also lower the temperature at which ice forms and can interact with membrane phospholipids to stabilize them.

Non-penetrating cryoprotectants, such as sucrose, trehalose, and polyvinylpyrrolidone (PVP), remain outside the cell. They act by drawing water out of the cell before freezing, thereby reducing intracellular ice formation, and by stabilizing the extracellular environment. They are often used in combination with penetrating cryoprotectants, particularly for cells that are sensitive to DMSO toxicity.

Cryoprotectants are not without their own toxicity. DMSO, for example, is cytotoxic at room temperature, and exposure should be minimized. The toxicity is both osmotic (due to the sudden influx of the compound) and chemical (due to its effects on protein structure and membrane integrity). This is why cryoprotectants are typically added slowly, at low temperature (on ice), and removed rapidly upon thawing.

Choosing the Right Cryoprotectant

The choice of cryoprotectant depends on the cell type, the intended use of the cells after thawing, and practical considerations of availability and cost.

Dimethyl Sulfoxide (DMSO)

DMSO is the most widely used cryoprotectant for mammalian cells. It is a small, highly polar molecule that readily penetrates cell membranes. It is typically used at a final concentration of 5% to 10% (v/v) in the freezing medium. For most adherent and suspension cell lines, 10% DMSO in complete growth medium supplemented with 10% to 20% fetal bovine serum (FBS) is a standard formulation.

DMSO has several advantages. It penetrates cells rapidly, so a short equilibration time (5–10 minutes on ice) is sufficient. It is effective across a broad range of cell types, from immortalized cell lines such as HeLa and HEK293 to primary cells and stem cells. It is also relatively inexpensive and widely available.

The main disadvantage of DMSO is its toxicity. At concentrations above 10%, or at temperatures above 4°C, DMSO can cause significant cell death. It also has effects on cellular differentiation; for example, DMSO can induce differentiation in some myeloid leukemia cell lines, which is undesirable if you are freezing those cells for experimental use. For clinical applications, DMSO must be removed from the final cell product, as it can cause adverse reactions in patients.

Glycerol

Glycerol was the first cryoprotectant discovered and remains useful for certain applications. It is used at concentrations of 10% to 20% (v/v). Glycerol penetrates cells more slowly than DMSO, so longer equilibration times (30–60 minutes on ice) are required. It is less toxic than DMSO at equivalent concentrations, which makes it a good choice for cells that are sensitive to DMSO, such as some primary cells and red blood cells.

However, glycerol is less effective than DMSO for many mammalian cell lines, and its slower penetration can be a disadvantage. It is also more viscous, which can complicate handling. For most cell culture applications, DMSO is the default choice, but glycerol is a viable alternative, particularly for erythrocytes and spermatozoa.

Alternatives and Considerations

For cells that are exceptionally sensitive to DMSO or glycerol, alternatives exist. Trehalose, a disaccharide, is a non-penetrating cryoprotectant that has been used successfully for freezing stem cells and other sensitive cell types. It is often used at concentrations of 100 to 200 mM in combination with a low concentration of DMSO (2% to 5%). Hydroxyethyl starch (HES) is another non-penetrating cryoprotectant that can partially replace DMSO. For some applications, such as the cryopreservation of oocytes and embryos, specialized protocols using ethylene glycol or propylene glycol are used.

The choice of cryoprotectant should also consider the downstream application. If the cells will be used for Cryopreservation of Animal Cells in a research setting, standard DMSO-based protocols are usually sufficient. If the cells are intended for clinical use, you may need to use a GMP-grade cryoprotectant and a formulation that minimizes residual DMSO. For bacterial cells, such as E. coli strains used for cloning, the cryoprotectant is often glycerol at 15% to 25% (v/v), as described in protocols for Making Competent Cells.

Cryoprotectant	Type	Typical Concentration	Penetration Rate	Relative Toxicity	Common Applications
DMSO	Penetrating	5–10% (v/v)	Fast	Moderate	Mammalian cell lines, stem cells
Glycerol	Penetrating	10–20% (v/v)	Slow	Low	Bacteria, erythrocytes, sperm
Trehalose	Non-penetrating	100–200 mM	N/A	Very low	Stem cells, sensitive primary cells
Ethylene glycol	Penetrating	10–15% (v/v)	Fast	Moderate	Oocytes, embryos
Hydroxyethyl starch	Non-penetrating	6–10% (w/v)	N/A	Very low	Hematopoietic stem cells

Preparing Cells for Freezing

The success of cryopreservation is largely determined by the state of the cells at the moment they are frozen. Freezing cannot rescue unhealthy cells; it can only preserve the quality that exists at the time of freezing.

Cell Health and Confluency

Cells should be in logarithmic growth phase, not at confluence, when frozen. Logarithmic-phase cells are metabolically active, have intact membranes, and are more likely to survive the freeze-thaw cycle. Confluent cells, by contrast, may be contact-inhibited, starved of nutrients, and accumulating metabolic waste products. They are more fragile and less likely to recover.

For adherent cells, the ideal confluency for freezing is 70% to 80%. At this density, the cells are still dividing and have not yet formed a fully confluent monolayer. For suspension cells, freeze them during mid-log phase, typically at a density of 0.5 to 1 × 10⁶ cells/mL. The culture medium should be fresh, and the cells should have been fed 24 hours before freezing to ensure they are in optimal metabolic state.

It is also essential to confirm that the cells are free of contamination before freezing. Mycoplasma contamination is a particular concern because it is invisible under a standard light microscope and can alter cell behavior without causing obvious cytopathic effects. If you are establishing a cell bank, perform a mycoplasma test before freezing. For routine freezing, a visual inspection for bacterial or fungal contamination under the microscope is a minimum requirement.

Freezing Medium Composition

The freezing medium is the solution in which the cells are suspended during freezing. Its composition is critical for cell survival. A standard freezing medium for mammalian cells is complete growth medium (the same medium the cells are cultured in) supplemented with 10% DMSO and 10% to 20% FBS. The FBS provides proteins that stabilize cell membranes and act as a source of lipids and growth factors. Some protocols use a higher concentration of serum (up to 90%) with 10% DMSO, which can improve viability for sensitive cells.

Serum-free freezing media are also available commercially. These are formulated with defined components, such as albumin, trehalose, and synthetic polymers, and are useful for cells that will be used in clinical applications or for experiments where serum components could confound results. However, serum-free media are generally more expensive and may not be as effective for all cell types.

The freezing medium should be prepared fresh or stored at 4°C and used within a few days. DMSO should be added to the medium just before use, as it can oxidize over time. The medium should be ice-cold when added to the cells, as this slows DMSO uptake and reduces toxicity.

Cell Density and Viability

The density at which cells are frozen affects their recovery. Too low a density can result in poor viability, as cells may not survive the dilution effects of thawing. Too high a density can lead to clumping and reduced recovery. A typical freezing density is 1 to 5 × 10⁶ viable cells per milliliter of freezing medium. For some cell types, such as primary cells or stem cells, lower densities (0.5 to 1 × 10⁶ cells/mL) are recommended.

Before freezing, assess cell viability using a dye exclusion method such as trypan blue. Only freeze cells with a viability of at least 90%. If viability is lower, culture the cells for a few more days, change the medium, or troubleshoot the culture conditions before attempting to freeze.

The procedure for preparing cells for freezing is as follows:

Harvest the cells. For adherent cells, remove the medium, wash with phosphate-buffered saline (PBS), and detach using trypsin-EDTA (0.25% trypsin, 1 mM EDTA). Incubate at 37°C for 2–5 minutes, then neutralize the trypsin with complete medium containing serum.
Transfer the cell suspension to a sterile centrifuge tube and count the cells using a hemocytometer or automated counter. Record the total cell number and viability.
Centrifuge the cells at 200 × g for 5 minutes at room temperature. Remove the supernatant carefully, leaving the cell pellet.
Resuspend the pellet in ice-cold freezing medium at the desired density (e.g., 1 × 10⁶ cells/mL). Pipette gently to avoid creating bubbles, which can damage cells.
Aliquot the cell suspension into cryovials, typically 1 mL per vial. Use cryovials that are rated for liquid nitrogen storage and have a seal that prevents leakage.
Place the vials on ice and proceed to the freezing step within 15 minutes to minimize DMSO exposure.

Controlled-Rate Freezing vs. Simple Freezing

The rate at which cells are cooled is one of the most important variables in cryopreservation. The goal is to cool the cells at a rate that balances the two competing injuries: solution effects from slow cooling and intracellular ice formation from fast cooling.

Cooling Rate and Cell Survival

For most mammalian cells, the optimal cooling rate is between 1°C and 3°C per minute. At this rate, the cell has time to dehydrate and equilibrate with the extracellular environment, but not so much time that it suffers from prolonged exposure to concentrated solutes. The optimal rate varies by cell type. For example, red blood cells survive best at cooling rates of 10°C to 100°C per minute, while stem cells often require slower rates of 0.5°C to 1°C per minute.

The cooling rate is not constant throughout the freezing process. As the extracellular solution freezes, latent heat is released, which can cause the temperature to plateau. This is why simple placement of vials in a −80°C freezer does not produce a linear cooling curve. The cooling rate is initially fast (as the vial cools from room temperature to the freezer temperature), then slows as the freezing point of the medium is reached, and then accelerates again once freezing is complete.

Using Mr. Frosty or Isopropanol Containers

The simplest method for achieving a controlled cooling rate is to use a passive cooling device such as a "Mr. Frosty" container (Nalgene). This is a sealed container that holds cryovials in a rack and contains 250 mL of isopropanol at the bottom. When placed in a −80°C freezer, the isopropanol cools slowly and provides a cooling rate of approximately −1°C per minute for the vials. This is because the isopropanol has a large thermal mass and its own freezing point (−89°C) is below the freezer temperature, so it does not freeze and continues to conduct heat away from the vials at a steady rate.

To use a Mr. Frosty container:

Ensure the container is filled with fresh isopropanol to the indicated line. Isopropanol should be replaced after every five uses, as it absorbs water and its cooling properties change.
Place the cryovials in the rack and insert the rack into the container.
Tighten the lid and place the container in a −80°C freezer for 12 to 24 hours.
After this period, transfer the vials to liquid nitrogen for long-term storage.

This method is simple, inexpensive, and adequate for most cell lines. It is the recommended approach for Cryopreservation of Cell Lines in a standard research laboratory.

Programmable Freezers

For cells that are particularly sensitive to cooling rate, or for applications where precise control is required, a programmable controlled-rate freezer is used. These devices cool the samples at a user-defined rate, typically by injecting liquid nitrogen into a chamber while monitoring the sample temperature with a thermocouple. A typical program for mammalian cells might be:

Cool from 4°C to −4°C at 1°C per minute.
Hold at −4°C for 5 minutes to allow for the release of latent heat of fusion.
Cool from −4°C to −40°C at 1°C per minute.
Cool from −40°C to −80°C at 10°C per minute.
Transfer to liquid nitrogen.

Programmable freezers are essential for cryopreserving oocytes, embryos, and some stem cell populations, where even small deviations in cooling rate can significantly reduce viability. They are also used in clinical and industrial settings where reproducibility and documentation are required. However, they are expensive and not necessary for routine cell line freezing.

Long-Term Storage and Thawing

Proper storage and thawing are as important as the freezing process itself. Mistakes at these stages can undo all the care taken during freezing.

Storage in Liquid Nitrogen

For long-term storage, cells should be kept at temperatures below −130°C, the glass transition temperature of water, at which all biological activity ceases. The standard method is storage in liquid nitrogen, either in the vapor phase (approximately −150°C to −190°C) or in the liquid phase (−196°C). Vapor-phase storage is generally preferred because it eliminates the risk of cross-contamination between vials that can occur if vials leak and are immersed in liquid nitrogen. It also avoids the risk of vials exploding upon thawing if liquid nitrogen has entered the vial.

Cells can be stored at −80°C for short periods, typically up to a few months, but viability will decline over time. For long-term storage, liquid nitrogen is essential. Under proper conditions, cells can be stored indefinitely. There are documented cases of viable cells being recovered after decades of storage in liquid nitrogen.

When storing vials, use a cryobox or a cane system to organize them. Ensure that the vials are clearly labeled with the cell line name, passage number, date, and the initials of the person who froze them. Use cryogenic labels or a permanent marker that can withstand low temperatures. For detailed guidance on labeling, see Cryopreservation Labels for Cells.

Rapid Thawing Protocol

Thawing should be rapid to minimize the time cells spend in the presence of high concentrations of cryoprotectant and to prevent ice recrystallization. The standard protocol is:

Remove the cryovial from liquid nitrogen storage. Do this quickly, as exposure to room temperature will begin the thawing process.
Place the vial in a 37°C water bath. Do not submerge the cap; keep the O-ring and cap out of the water to prevent contamination.
Agitate the vial gently until only a small ice crystal remains. This should take 1 to 2 minutes. Do not leave the vial in the water bath longer than necessary, as overheating can damage the cells.
Wipe the vial with 70% ethanol and transfer it to a biosafety cabinet.
Using a sterile pipette, transfer the cell suspension to a centrifuge tube containing 10 mL of pre-warmed complete growth medium. Add the cells dropwise with gentle swirling to dilute the DMSO gradually.
Centrifuge at 200 × g for 5 minutes. Remove the supernatant, which contains the DMSO, and resuspend the cell pellet in fresh growth medium.
Transfer the cells to a culture flask and place in the incubator at 37°C, 5% CO₂.

The rapid dilution and centrifugation step is critical because DMSO is toxic at 37°C. Leaving cells in DMSO-containing medium for even 10 minutes after thawing can significantly reduce viability.

Post-Thaw Viability Assessment

After thawing, assess cell viability to confirm that the freezing process was successful. The simplest method is trypan blue exclusion, performed immediately after thawing and again after 24 hours of culture. Viability immediately after thawing should be at least 70% for most cell lines, and many achieve 80% to 90%. Viability after 24 hours is a better indicator of long-term recovery, as some cells that survive the initial thaw may die later due to sublethal damage.

For a more rigorous assessment, you can perform a clonogenic assay, in which a known number of cells are plated and the number of colonies formed is counted after 7 to 14 days. This measures the reproductive viability of the cells, which is the ultimate test of successful cryopreservation.

Quality Control and Record Keeping

Cryopreservation is only useful if you can find the cells you need and trust that they are what you think they are. Rigorous record keeping and quality control are therefore essential components of any cell banking program.

Labeling and Inventory

Every cryovial must be labeled with, at minimum: the cell line name, passage number, date of freezing, the freezing medium used, and the initials of the operator. Use labels that are resistant to alcohol, cold, and moisture. Cryogenic labels are available that adhere at −196°C and survive thawing.

Maintain a logbook or electronic database that records the same information, along with the number of vials frozen, the location of each vial in the liquid nitrogen tank, and the results of any quality control tests. This inventory should be updated every time vials are added or removed. A well-maintained inventory prevents the common problem of "freezer archaeology," where researchers are forced to thaw multiple vials to find one that is viable.

Viability Testing

Each new batch of frozen cells should be tested by thawing one vial and assessing viability, as described above. This is the only way to confirm that the freezing process worked and that the cells are suitable for future use. The results should be recorded in the cell bank log. If viability is below expectations, investigate the cause—was the cell health poor before freezing? Was the cooling rate correct? Was the DMSO concentration accurate?

For cell lines that will be used extensively, it is advisable to create a two-tier banking system: a master cell bank (MCB) of cells frozen at the lowest possible passage number, and a working cell bank (WCB) derived from the MCB. The WCB is used for routine experiments, and the MCB is reserved for replenishing the WCB. This system minimizes the number of passages and reduces the risk of genetic drift.

Contamination Checks

Before freezing, and again after thawing, check the cells for contamination. This includes visual inspection for bacteria and fungi, as well as testing for mycoplasma. Mycoplasma contamination is a silent killer—it does not cause visible turbidity or pH changes, but it can alter cell growth, protein expression, and response to drugs. Mycoplasma testing should be performed regularly, using either a PCR-based assay or a Hoechst stain, and any contaminated cultures should be discarded immediately.

Common Pitfalls and Troubleshooting

Even with a solid protocol, cryopreservation can fail. The following are the most common pitfalls and how to avoid them.

Pitfall: Inadequate Cooling Rate

If cells are frozen by simply placing vials directly into a −80°C freezer without a controlled-rate device, the cooling rate is too fast (approximately 10°C to 20°C per minute), leading to intracellular ice formation and poor viability. The solution is to use a Mr. Frosty container or a programmable freezer. If you must freeze without a controlled-rate device, you can try a "poor man's" approach: place the vials in a Styrofoam box with thick walls before putting them in the freezer, which slows the cooling rate. However, this is not reproducible and is not recommended for valuable cells.

Pitfall: DMSO Toxicity

DMSO is toxic at room temperature, and prolonged exposure before freezing or after thawing can kill cells. To minimize toxicity, keep the cells on ice during the entire freezing procedure, add the DMSO-containing medium slowly, and freeze the cells within 15 minutes of adding the cryoprotectant. Upon thawing, dilute the DMSO immediately and remove it by centrifugation. If your cells are particularly sensitive to DMSO, consider using a lower concentration (5%) or switching to an alternative cryoprotectant.

Pitfall: Poor Cell Health Before Freezing

Freezing cells that are overconfluent, starved, or stressed will result in poor recovery. Always freeze cells in logarithmic growth phase, at 70% to 80% confluency for adherent cells, and ensure the medium was changed 24 hours before freezing. If the cells have been in culture for many passages, their viability may be compromised; consider thawing an earlier passage and using those cells for freezing.

Pitfall: Slow Thawing

Thawing cells slowly, such as at room temperature or on ice, allows ice crystals to recrystallize and damage the cells. It also prolongs DMSO exposure. Always thaw cells rapidly in a 37°C water bath, and transfer them to fresh medium as quickly as possible.

Pitfall: Contamination During Storage

Vials stored in liquid nitrogen can become contaminated if the seal fails and liquid nitrogen enters the vial. This is a particular risk with vials that are not designed for liquid-phase storage. To avoid this, use vials with internal threads and O-rings, store vials in the vapor phase, and seal vials in plastic cryobags or use heat-sealed straws for added protection.

Pitfall: Freezing Too Many Cells per Vial

Freezing at too high a density can lead to clumping and reduced viability. The standard density of 1 to 5 × 10⁶ cells/mL is appropriate for most cell lines. If you need more cells than this, freeze multiple vials rather than increasing the density.

Summary and Best Practices

Cryopreservation is a reliable technique when performed correctly. The key steps are: start with healthy cells in logarithmic growth, use an appropriate cryoprotectant at the correct concentration, cool at a controlled rate of approximately 1°C per minute, store at temperatures below −130°C, and thaw rapidly with immediate removal of the cryoprotectant.

Checklist for Freezing Cells

Confirm cells are healthy, mycoplasma-free, and in logarithmic growth phase (70–80% confluency for adherent cells).
Prepare ice-cold freezing medium: complete growth medium + 10% FBS + 10% DMSO (or as optimized for your cell type).
Harvest cells using trypsin-EDTA (adherent) or direct transfer (suspension).
Count cells and assess viability using trypan blue. Proceed only if viability is ≥90%.
Centrifuge at 200 × g for 5 minutes and remove supernatant.
Resuspend pellet in ice-cold freezing medium at 1–5 × 10⁶ cells/mL.
Aliquot 1 mL into labeled cryovials.
Place vials in a Mr. Frosty container (with fresh isopropanol) or a programmable freezer.
Cool at approximately −1°C per minute to −80°C.
Transfer vials to liquid nitrogen storage within 24 hours.
Record all details in the cell bank logbook.
Thaw one vial after 24–48 hours to verify viability.

Final Recommendations

Always freeze cells at the lowest practical passage number to preserve the original phenotype and genotype. Use a two-tier banking system (master and working banks) for valuable cell lines. Never rely on a single freezer; maintain backup copies of critical cell lines in separate locations. And finally, document everything—the success of future experiments may depend on the quality of your frozen stocks.

Frequently Asked Questions

How do you freeze cells for cryopreservation?

To freeze cells, first ensure they are healthy and in logarithmic growth phase. Harvest the cells, count them, and assess viability. Resuspend the cell pellet in ice-cold freezing medium containing 10% DMSO and 10–20% serum at a density of 1–5 × 10⁶ cells/mL. Aliquot into cryovials and cool at a controlled rate of approximately 1°C per minute to −80°C, using a Mr. Frosty container or a programmable freezer. After 12–24 hours, transfer the vials to liquid nitrogen for long-term storage.

What is the best freezing medium for cells?

The best freezing medium depends on the cell type. For most mammalian cell lines, a standard formulation is complete growth medium supplemented with 10% DMSO and 10–20% fetal bovine serum. For serum-sensitive or clinical applications, use a commercially available serum-free freezing medium containing defined components such as albumin and trehalose. For bacterial cells, use 15–25% glycerol in the culture medium.

Why is DMSO used in cell freezing?

DMSO is used because it is a penetrating cryoprotectant that enters cells and prevents ice crystal formation. It works by colligatively lowering the freezing point of the cytoplasm, reducing the amount of water that leaves the cell during freezing, and stabilizing cell membranes. It is effective at a concentration of 5–10% and penetrates cells rapidly, making it suitable for a wide range of cell types.

How fast should cells be frozen?

Most mammalian cells should be cooled at a rate of approximately 1°C to 3°C per minute. This rate balances two competing injuries: too slow causes damage from concentrated solutes, and too fast causes intracellular ice formation. A Mr. Frosty container provides a cooling rate of approximately −1°C per minute when placed in a −80°C freezer.

Can I freeze cells at -80°C without a controlled-rate freezer?

Yes, but only for short-term storage. You can place vials in a −80°C freezer, but the cooling rate will be uncontrolled and likely too fast, reducing viability. For better results, use a Mr. Frosty container or another passive cooling device. Cells stored at −80°C will gradually lose viability over months; for long-term storage, transfer them to liquid nitrogen.

How long can cells be stored in liquid nitrogen?

Cells can be stored indefinitely in liquid nitrogen at temperatures below −130°C. At these temperatures, all biological activity ceases, and cells have been successfully recovered after decades of storage. The key is to maintain a consistent temperature and avoid temperature fluctuations.

What happens if you freeze cells too quickly?

If cells are frozen too quickly, water does not have time to leave the cell, and intracellular ice forms. Ice crystals puncture the plasma membrane and damage intracellular structures, leading to cell death upon thawing. Rapid freezing is a common cause of poor viability after cryopreservation.

How do you thaw frozen cells correctly?

Thaw cells rapidly by placing the cryovial in a 37°C water bath for 1–2 minutes, until only a small ice crystal remains. Wipe the vial with 70% ethanol, transfer the contents to a tube containing 10 mL of pre-warmed growth medium, and centrifuge to remove the DMSO. Resuspend the pellet in fresh medium and plate the cells. Work quickly to minimize DMSO toxicity.

Key Takeaways

Cryopreservation preserves cell viability by halting metabolic activity at ultra-low temperatures, but the freezing process itself is damaging and must be carefully managed.
The two main injuries during freezing are intracellular ice crystal formation (from rapid cooling) and solution effects from concentrated solutes (from slow cooling); the optimal cooling rate balances these.
DMSO is the most common cryoprotectant, used at 5–10% (v/v), but it is toxic at room temperature and must be added cold and removed rapidly upon thawing.
Always freeze cells in logarithmic growth phase at 70–80% confluency, with a viability of at least 90%, and use a controlled cooling rate of approximately 1°C per minute.
Long-term storage requires temperatures below −130°C, typically in liquid nitrogen vapor phase; cells stored at −80°C will lose viability over time.
Thawing must be rapid (37°C water bath) with immediate dilution and removal of the cryoprotectant to maximize recovery.
Maintain rigorous records, label vials clearly, test viability after thawing, and use a two-tier banking system to protect valuable cell lines.